STOCK TITAN

CareCloud Acquires RevNu Medical Management, Completing Second Acquisition in 31 Days

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)

CareCloud (NASDAQ: CCLD) has announced the acquisition of RevNu Medical Management, an audiology-focused revenue cycle management company based in Westminster, California. This marks CareCloud's second acquisition in 31 days, following the MesaBilling deal.

RevNu's founder Clay Gililland, who owns over 30 hearing health clinics in Southern California, will integrate with CareCloud to leverage their technology and automation capabilities. Daniel Davis, former RevNu CEO, will lead CareCloud's new hearing healthcare division as President.

The acquisition targets the U.S. audiology market, which includes approximately 24,000 employed audiologists and hearing aid specialists, with annual hearing aid spending exceeding $5 billion. The segment remains minimally penetrated by outsourced RCM vendors. The acquisition is expected to be accretive within 90 days, with consideration paid quarterly based on retained revenue.

CareCloud (NASDAQ: CCLD) ha annunciato l'acquisizione di RevNu Medical Management, una società di gestione del ciclo di entrate focalizzata sull'audiologia con sede a Westminster, California. Questo segna la seconda acquisizione di CareCloud in 31 giorni, dopo l'accordo con MesaBilling.

Il fondatore di RevNu, Clay Gililland, che possiede oltre 30 cliniche di salute uditiva nel sud della California, si integrerà con CareCloud per sfruttare le loro tecnologie e capacità di automazione. Daniel Davis, ex CEO di RevNu, guiderà la nuova divisione di assistenza sanitaria uditiva di CareCloud come Presidente.

L'acquisizione mira al mercato audiologico statunitense, che include circa 24.000 audiologi e specialisti in apparecchi acustici impiegati, con una spesa annuale per apparecchi acustici che supera i 5 miliardi di dollari. Questo segmento rimane minimamente penetrato dai fornitori di RCM esternalizzati. Si prevede che l'acquisizione sarà accrescitiva entro 90 giorni, con un pagamento considerato trimestralmente basato sul reddito trattenuto.

CareCloud (NASDAQ: CCLD) ha anunciado la adquisición de RevNu Medical Management, una empresa de gestión del ciclo de ingresos centrada en la audiología con sede en Westminster, California. Esto marca la segunda adquisición de CareCloud en 31 días, después del acuerdo con MesaBilling.

El fundador de RevNu, Clay Gililland, que posee más de 30 clínicas de salud auditiva en el sur de California, se integrará con CareCloud para aprovechar su tecnología y capacidades de automatización. Daniel Davis, ex CEO de RevNu, liderará la nueva división de atención sanitaria auditiva de CareCloud como Presidente.

La adquisición se dirige al mercado de audiología de EE. UU., que incluye aproximadamente 24,000 audiólogos y especialistas en audífonos empleados, con un gasto anual en audífonos que supera los 5 mil millones de dólares. Este segmento sigue estando mínimamente penetrado por proveedores de RCM externalizados. Se espera que la adquisición sea accretiva dentro de 90 días, con una consideración pagada trimestralmente basada en los ingresos retenidos.

CareCloud (NASDAQ: CCLD)는 캘리포니아 웨스트민스터에 본사를 둔 청각학 중심의 수익 주기 관리 회사인 RevNu Medical Management를 인수했다고 발표했습니다. 이는 MesaBilling 거래에 이어 CareCloud의 31일 만의 두 번째 인수입니다.

RevNu의 창립자 클레이 길리랜드는 남부 캘리포니아에 30개 이상의 청각 건강 클리닉을 소유하고 있으며, CareCloud와 통합하여 그들의 기술 및 자동화 능력을 활용할 것입니다. 전 RevNu CEO인 다니엘 데이비스는 CareCloud의 새로운 청각 건강 관리 부서를 사장으로 이끌게 됩니다.

이번 인수는 약 24,000명의 고용된 청각학자와 보청기 전문가를 포함하는 미국 청각학 시장을 목표로 하며, 연간 보청기 지출은 50억 달러를 초과합니다. 이 부문은 외부 RCM 공급업체에 의해 최소한으로 침투되어 있습니다. 이번 인수는 90일 이내에 수익이 증가할 것으로 예상되며, 유지된 수익에 따라 분기별로 지급됩니다.

CareCloud (NASDAQ: CCLD) a annoncé l'acquisition de RevNu Medical Management, une entreprise de gestion du cycle de revenus axée sur l'audiologie, basée à Westminster, en Californie. Cela marque la deuxième acquisition de CareCloud en 31 jours, après l'accord avec MesaBilling.

Le fondateur de RevNu, Clay Gililland, qui possède plus de 30 cliniques de santé auditive dans le sud de la Californie, s'intégrera à CareCloud pour tirer parti de leur technologie et de leurs capacités d'automatisation. Daniel Davis, ancien PDG de RevNu, dirigera la nouvelle division de soins de santé auditive de CareCloud en tant que Président.

L'acquisition vise le marché de l'audiologie aux États-Unis, qui comprend environ 24 000 audiologistes et spécialistes des appareils auditifs employés, avec des dépenses annuelles en appareils auditifs dépassant 5 milliards de dollars. Ce segment reste peu pénétré par les fournisseurs de RCM externalisés. L'acquisition devrait être accretive dans les 90 jours, avec une rémunération versée trimestriellement en fonction des revenus conservés.

CareCloud (NASDAQ: CCLD) hat die Übernahme von RevNu Medical Management angekündigt, einem auf Audiologie spezialisierten Unternehmen für das Management von Einnahmenzyklen mit Sitz in Westminster, Kalifornien. Dies markiert die zweite Übernahme von CareCloud innerhalb von 31 Tagen, nach dem Deal mit MesaBilling.

Der Gründer von RevNu, Clay Gililland, der über 30 Hörgesundheitskliniken in Südkalifornien besitzt, wird sich mit CareCloud zusammenschließen, um deren Technologie und Automatisierungsmöglichkeiten zu nutzen. Daniel Davis, ehemaliger CEO von RevNu, wird die neue Abteilung für Hörgesundheitsversorgung von CareCloud als Präsident leiten.

Die Übernahme zielt auf den US-Audiologiemarkt ab, der etwa 24.000 angestellte Audiologen und Hörgeräte-Spezialisten umfasst, wobei die jährlichen Ausgaben für Hörgeräte 5 Milliarden Dollar übersteigen. Dieses Segment ist bislang nur minimal von externen RCM-Anbietern durchdrungen. Die Übernahme wird voraussichtlich innerhalb von 90 Tagen ertragssteigernd sein, wobei die Vergütung vierteljährlich basierend auf den erzielten Einnahmen gezahlt wird.

Positive
  • Expansion into underserved audiology market worth $5B+ annually
  • Expected to be accretive within 90 days
  • Strategic acquisition of a leading RCM provider in hearing healthcare
  • Integration of RevNu's expertise with CareCloud's AI-powered technology
  • Access to established network of 30+ hearing health clinics
Negative
  • RevNu described as 'relatively small' in current market position
  • Payment structure tied to quarterly retained revenue performance
  • Integration costs and challenges in new specialty market

Insights

CareCloud's acquisition of RevNu Medical Management represents a strategic expansion into the specialized audiology market. This move is particularly compelling as it's CareCloud's second acquisition in just 31 days, demonstrating aggressive execution of their growth strategy.

The deal structure is financially prudent, with consideration paid quarterly based on retained revenue, effectively tying acquisition costs to actual performance. The expected accretion within 90 days suggests minimal integration challenges and near-term financial benefits.

The U.S. audiology market represents a substantial opportunity with 24,000 employed professionals and annual hearing aid spending exceeding $5 billion. Crucially, this segment remains minimally penetrated by outsourced revenue cycle management vendors, creating significant growth potential for CareCloud.

By retaining RevNu's leadership expertise—particularly Daniel Davis as President of the new hearing healthcare division—CareCloud ensures continuity of specialized knowledge and client relationships. The founder's dual position as both RevNu's creator and owner of 30+ hearing health clinics provides valuable industry connections and credibility.

This acquisition aligns perfectly with CareCloud's apparent strategy of targeting underserved healthcare niches where they can leverage their AI-powered technology to gain market leadership, rather than competing in more saturated segments.

SOMERSET, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leading provider of practice management, healthcare technology and AI-driven solutions to medical practices across the country, today announced the acquisition of RevNu Medical Management (“RevNu”), an emerging audiology-focused revenue cycle management (“RCM”) company based in Westminster, California.

“We’ve spent years building trusted relationships within the audiology community, and we couldn’t be more excited to join forces with CareCloud,” said Clay Gililland, founder of RevNu. “That experience has given us a deep understanding of the industry’s needs—insights we’re excited to put into action as RevNu joins CareCloud. As both the founder of RevNu and the owner of more than 30 hearing health clinics across Southern California, I’m confident that our clients and the broader industry will benefit greatly from CareCloud’s technology, automation, and scale.”

“The closing of RevNu marks a significant milestone in our acquisition strategy and a strategic expansion into a specialty care market lacking a clear leader,” said Stephen Snyder, Co-CEO of CareCloud. “RevNu’s deep expertise in audiology and strong, trusted client relationships make it an exceptional addition as we accelerate growth in underserved markets. By deploying our AI-powered revenue cycle management and advanced technology infrastructure in the hearing healthcare space, we are well positioned to expand our footprint, capture new market share, and accelerate CareCloud’s overall growth.”

The U.S. audiology market is believed to include approximately 24,000 employed audiologists and hearing aid specialists, with annual spending on hearing aids exceeding $5 billion. Despite this scale, the segment remains minimally penetrated by outsourced RCM and practice management vendors. RevNu—while still relatively small—is among the leading RCM providers in this space. With the added resources and technological depth of CareCloud, the combined entity is well-positioned to accelerate growth.

“Through this combination, our clients will gain access to CareCloud’s powerful suite of tools, advanced infrastructure, and culture of innovation—all of which will improve outcomes and unlock new growth potential,” said Daniel Davis, former CEO of RevNu, who will lead CareCloud’s growth as President of its new hearing healthcare division. “I’m excited to spearhead the expansion of CareCloud’s audiology and hearing aid billing division and build on the foundation RevNu has created to capture new market share and drive growth.”

The RevNu acquisition, like the MesaBilling acquisition closed a month ago, is expected to be accretive within ninety days. Consideration will be paid quarterly, based on retained revenue.

About CareCloud 

CareCloud brings disciplined innovation and generative AI to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health at www.carecloud.com. 

Follow CareCloud on LinkedIn, X and Facebook.

Disclaimer 

This press release is for information purposes only, and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction. 

Forward-Looking Statements 

This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology. 

Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct.

Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions. 

These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission. 

The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made. 

SOURCE CareCloud 

Company Contact: 

Norman Roth 
Interim Chief Financial Officer and Corporate Controller 
CareCloud, Inc.
nroth@carecloud.com 

Investor Contact:

Stephen Snyder 
Co-Chief Executive Officer 
CareCloud, Inc. 
ir@carecloud.com 


FAQ

What is the market size for CareCloud's (CCLD) new audiology acquisition?

The U.S. audiology market includes approximately 24,000 audiologists and hearing aid specialists, with annual hearing aid spending exceeding $5 billion.

When will RevNu's acquisition be accretive to CareCloud (CCLD)?

The acquisition is expected to be accretive within 90 days of closing.

How will CareCloud (CCLD) pay for the RevNu acquisition?

Consideration will be paid quarterly, based on retained revenue performance.

Who will lead CareCloud's (CCLD) new hearing healthcare division?

Daniel Davis, former CEO of RevNu, will serve as President of CareCloud's new hearing healthcare division.

What strategic advantage does RevNu bring to CareCloud (CCLD)?

RevNu brings deep expertise in audiology, established client relationships, and access to an underserved market lacking a clear leader.
Carecloud Inc

NASDAQ:CCLD

CCLD Rankings

CCLD Latest News

CCLD Stock Data

52.68M
34.55M
18.15%
4.3%
0.78%
Health Information Services
Services-prepackaged Software
Link
United States
SOMERSET